Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Injection of Adipose-Derived Stromal Cells in the Knee of Patients with Severe Osteoarthritis has a Systemic Effect and Promotes an Anti-Inflammatory Phenotype of Circulating Immune Cells.

Pers YM, Quentin J, Feirreira R, Espinoza F, Abdellaoui N, Erkilic N, Cren M, Dufourcq-Lopez E, Pullig O, Nöth U, Jorgensen C, Louis-Plence P.

Theranostics. 2018 Nov 5;8(20):5519-5528. doi: 10.7150/thno.27674. eCollection 2018.

2.

A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis).

Grandemange S, Sanchez E, Louis-Plence P, Tran Mau-Them F, Bessis D, Coubes C, Frouin E, Seyger M, Girard M, Puechberty J, Costes V, Rodière M, Carbasse A, Jeziorski E, Portales P, Sarrabay G, Mondain M, Jorgensen C, Apparailly F, Hoppenreijs E, Touitou I, Geneviève D.

Ann Rheum Dis. 2017 Jul;76(7):1191-1198. doi: 10.1136/annrheumdis-2016-210021. Epub 2016 Dec 13.

PMID:
27965258
3.

Cellular senescence impact on immune cell fate and function.

Vicente R, Mausset-Bonnefont AL, Jorgensen C, Louis-Plence P, Brondello JM.

Aging Cell. 2016 Jun;15(3):400-6. doi: 10.1111/acel.12455. Epub 2016 Feb 22. Review.

4.

Nonclassical CD4+CD49b+ Regulatory T Cells as a Better Alternative to Conventional CD4+CD25+ T Cells To Dampen Arthritis Severity.

Vicente R, Quentin J, Mausset-Bonnefont AL, Chuchana P, Martire D, Cren M, Jorgensen C, Louis-Plence P.

J Immunol. 2016 Jan 1;196(1):298-309. doi: 10.4049/jimmunol.1501069. Epub 2015 Nov 20.

5.

Systemic LPS Translocation Activates Cross-Presenting Dendritic Cells but Is Dispensable for the Breakdown of CD8+ T Cell Peripheral Tolerance in Irradiated Mice.

Espinosa-Carrasco G, Villard M, Le Saout C, Louis-Plence P, Vicente R, Hernandez J.

PLoS One. 2015 Jun 15;10(6):e0130041. doi: 10.1371/journal.pone.0130041. eCollection 2015.

6.

Versatile polyion complex micelles for peptide and siRNA vectorization to engineer tolerogenic dendritic cells.

Mebarek N, Vicente R, Aubert-Pouëssel A, Quentin J, Mausset-Bonnefont AL, Devoisselle JM, Jorgensen C, Bégu S, Louis-Plence P.

Eur J Pharm Biopharm. 2015 May;92:216-27. doi: 10.1016/j.ejpb.2015.03.013. Epub 2015 Mar 18.

PMID:
25796349
7.

Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis.

Asnagli H, Martire D, Belmonte N, Quentin J, Bastian H, Boucard-Jourdin M, Fall PB, Mausset-Bonnefont AL, Mantello-Moreau A, Rouquier S, Marchetti I, Jorgensen C, Foussat A, Louis-Plence P.

Arthritis Res Ther. 2014 May 22;16(3):R115. doi: 10.1186/ar4567.

8.

Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.

Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, Quentin J, Jorgensen C, Decker P, Boissier MC, Louis-Plence P, Bessis N.

Arthritis Rheumatol. 2014 Feb;66(2):273-83. doi: 10.1002/art.38246.

9.

The role of miR-155 in regulatory T cells and rheumatoid arthritis.

Spoerl D, Duroux-Richard I, Louis-Plence P, Jorgensen C.

Clin Immunol. 2013 Jul;148(1):56-65. doi: 10.1016/j.clim.2013.03.010. Epub 2013 Mar 29. Review.

PMID:
23649045
10.

Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis.

Présumey J, Courties G, Louis-Plence P, Escriou V, Scherman D, Pers YM, Yssel H, Pène J, Kyburz D, Gay S, Jorgensen C, Apparailly F.

Ann Rheum Dis. 2013 Oct;72(10):1717-24. doi: 10.1136/annrheumdis-2012-202403. Epub 2013 Jan 12.

11.

DX5+ CD4+ T cells modulate CD4+ T-cell response via inhibition of IL-12 production by DCs.

el Bannoudi H, Han WG, Stoop JN, Louis-Plence P, Huizinga TW, Toes RE.

Eur J Immunol. 2013 Feb;43(2):439-46. doi: 10.1002/eji.201242796.

12.

Development of tripartite polyion micelles for efficient peptide delivery into dendritic cells without altering their plasticity.

Boudier A, Aubert-Pouëssel A, Mebarek N, Chavanieu A, Quentin J, Martire D, Boukhaddaoui H, Gérardin C, Jorgensen C, Devoisselle JM, Louis-Plence P, Bégu S.

J Control Release. 2011 Sep 5;154(2):156-63. doi: 10.1016/j.jconrel.2011.05.016. Epub 2011 May 19.

PMID:
21624406
13.

DX5(+)CD4(+) T cells modulate cytokine production by CD4(+) T cells towards IL-10 via the production of IL-4.

Han WG, van der Voort EI, el Bannoudi H, Louis-Plence P, Huizinga TW, Toes RE.

Eur J Immunol. 2010 Oct;40(10):2731-40. doi: 10.1002/eji.201040574.

14.

Adoptive transfer of IL-10-secreting CD4+CD49b+ regulatory T cells suppresses ongoing arthritis.

Charbonnier LM, Han WG, Quentin J, Huizinga TW, Zwerina J, Toes RE, Jorgensen C, Louis-Plence P.

J Autoimmun. 2010 Jun;34(4):390-9. doi: 10.1016/j.jaut.2009.10.003. Epub 2009 Oct 31.

PMID:
19880290
15.

DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.

Han WG, Schuurhuis DH, Fu N, Camps M, van Duivenvoorde LM, Louis-Plence P, Franken KL, Huizinga TW, Melief CJ, Toes RE, Ossendorp F.

Eur J Immunol. 2009 Jul;39(7):1765-73. doi: 10.1002/eji.200838842.

16.

Tripartite siRNA micelles as controlled delivery systems for primary dendritic cells.

Boudier A, Aubert-Pouëssel A, Gérardin C, Devoisselle JM, Bégu S, Louis-Plence P, Quentin J, Jorgensen C.

Drug Dev Ind Pharm. 2009 Aug;35(8):950-8. doi: 10.1080/03639040802716653.

PMID:
19274590
17.

The control of dendritic cell maturation by pH-sensitive polyion complex micelles.

Boudier A, Aubert-Pouëssel A, Louis-Plence P, Gérardin C, Jorgensen C, Devoisselle JM, Bégu S.

Biomaterials. 2009 Jan;30(2):233-41. doi: 10.1016/j.biomaterials.2008.09.033. Epub 2008 Oct 11.

PMID:
18851879
18.

Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor.

Fritz V, Noël D, Bouquet C, Opolon P, Voide R, Apparailly F, Louis-Plence P, Bouffi C, Drissi H, Xie C, Perricaudet M, Müller R, Schwarz E, Jorgensen C.

Stem Cells. 2008 Nov;26(11):2981-90. doi: 10.1634/stemcells.2008-0139. Epub 2008 Aug 28.

19.

Transient down-regulation of cbfa1/Runx2 by RNA interference in murine C3H10T1/2 mesenchymal stromal cells delays in vitro and in vivo osteogenesis, but does not overtly affect chondrogenesis.

Gordeladze JO, Noël D, Bony C, Apparailly F, Louis-Plence P, Jorgensen C.

Exp Cell Res. 2008 Apr 15;314(7):1495-506. doi: 10.1016/j.yexcr.2007.12.023. Epub 2008 Jan 12.

PMID:
18313048
20.

Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms.

van Duivenvoorde LM, Han WG, Bakker AM, Louis-Plence P, Charbonnier LM, Apparailly F, van der Voort EI, Jorgensen C, Huizinga TW, Toes RE.

J Immunol. 2007 Aug 1;179(3):1506-15.

21.

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.

Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, Apparailly F, Cantos C, Jorgensen C, Noël D.

Stem Cells. 2007 Aug;25(8):2025-32. Epub 2007 May 17.

22.

Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes.

Djouad F, Delorme B, Maurice M, Bony C, Apparailly F, Louis-Plence P, Canovas F, Charbord P, Noël D, Jorgensen C.

Arthritis Res Ther. 2007;9(2):R33.

23.

Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model.

Fritz V, Louis-Plence P, Apparailly F, Noël D, Voide R, Pillon A, Nicolas JC, Müller R, Jorgensen C.

Bone. 2007 Apr;40(4):1032-40. Epub 2006 Dec 15.

PMID:
17251073
24.

Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells.

Djouad F, Bony C, Apparailly F, Louis-Plence P, Jorgensen C, Noël D.

Transplantation. 2006 Oct 27;82(8):1060-6.

PMID:
17060855
25.

Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells.

Charbonnier LM, van Duivenvoorde LM, Apparailly F, Cantos C, Han WG, Noël D, Duperray C, Huizinga TW, Toes RE, Jorgensen C, Louis-Plence P.

J Immunol. 2006 Sep 15;177(6):3806-13.

26.

A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis.

Khoury M, Bigey P, Louis-Plence P, Noel D, Rhinn H, Scherman D, Jorgensen C, Apparailly F.

J Gene Med. 2006 Aug;8(8):1027-36.

PMID:
16733831
27.

Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.

Khoury M, Louis-Plence P, Escriou V, Noel D, Largeau C, Cantos C, Scherman D, Jorgensen C, Apparailly F.

Arthritis Rheum. 2006 Jun;54(6):1867-77.

28.

Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells.

Djouad F, Bony C, Häupl T, Uzé G, Lahlou N, Louis-Plence P, Apparailly F, Canovas F, Rème T, Sany J, Jorgensen C, Noël D.

Arthritis Res Ther. 2005;7(6):R1304-15. Epub 2005 Sep 20.

29.

Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noël D.

Arthritis Rheum. 2005 May;52(5):1595-603.

30.

Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints.

Apparailly F, Khoury M, Vervoordeldonk MJ, Adriaansen J, Gicquel E, Perez N, Riviere C, Louis-Plence P, Noel D, Danos O, Douar AM, Tak PP, Jorgensen C.

Hum Gene Ther. 2005 Apr;16(4):426-34.

PMID:
15871674
31.

Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells.

van Duivenvoorde LM, Louis-Plence P, Apparailly F, van der Voort EI, Huizinga TW, Jorgensen C, Toes RE.

Arthritis Rheum. 2004 Oct;50(10):3354-64.

32.

Specific overexpression of rheumatoid arthritis-associated HLA-DR alleles and presentation of low-affinity peptides.

Kerlan-Candon S, Louis-Plence P, Wiedemann A, Combe B, Clot J, Eliaou JF, Pinet V.

Arthritis Rheum. 2001 Jun;44(6):1281-92.

33.

The down-regulation of HLA-DM gene expression in rheumatoid arthritis is not related to their promoter polymorphism.

Louis-Plence P, Kerlan-Candon S, Morel J, Combe B, Clot J, Pinet V, Eliaou JF.

J Immunol. 2000 Nov 1;165(9):4861-9.

34.

RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency.

Nagarajan UM, Louis-Plence P, DeSandro A, Nilsen R, Bushey A, Boss JM.

Immunity. 1999 Feb;10(2):153-62. Erratum in: Immunity 1999 Mar;10(3):399.

35.

CREB regulates MHC class II expression in a CIITA-dependent manner.

Moreno CS, Beresford GW, Louis-Plence P, Morris AC, Boss JM.

Immunity. 1999 Feb;10(2):143-51.

37.

HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region.

Westerheide SD, Louis-Plence P, Ping D, He XF, Boss JM.

J Immunol. 1997 May 15;158(10):4812-21.

PMID:
9144496
38.

Qualitative and quantitative analysis of HLA-DRB gene expression.

Vincent R, Louis-Plence P, Gaillard F, Clot J, Eliaou JF.

J Rheumatol. 1997 Jan;24(1):225-6.

PMID:
9002047

Supplemental Content

Loading ...
Support Center